Golden Dome is the administration's plan for a national missile defense shield, with interceptors in orbit as well as on the ground. The Pentagon puts the cost at $185 billion; outside estimates run much higher. In April the Space Force named 12 companies to develop the space-based interceptor layer, and five of them are listed in the US. We looked at where each one's valuation sits against its own five-year history, as of October 5, 2026.
If you only read one thing
The short version: Lockheed Martin, Northrop Grumman, General Dynamics and Booz Allen Hamilton all won space-based interceptor awards, and all four trade in the bottom quarter of their own five-year EV/Sales range. RTX, the fifth, sits at the 78th percentile. The awards are small next to these companies' revenue, and $17.1 billion of the $17.9 billion fiscal 2027 Golden Dome request depends on a reconciliation bill that has not passed.
Who won what
The Space Force awarded 20 agreements worth up to $3.2 billion to 12 companies: Anduril, Booz Allen Hamilton, General Dynamics Mission Systems, GITAI USA, Lockheed Martin, Northrop Grumman, Quindar, Raytheon, Sci-Tec, SpaceX, True Anomaly and Turion Space. The goal is a demonstration of interceptors in low Earth orbit by 2028. The agreements are prototype deals, so they do not commit the government to buy anything at scale.
Missile-tracking satellites, which a shield would depend on, have gone to others. In July, L3Harris won up to $955 million for missile-tracking satellites, and Rocket Lab won an $816 million Space Development Agency tracking-layer contract.
The takeaway: Five listed companies hold interceptor awards, but the awards fund demonstrations, and $3.2 billion split 12 ways is small next to a single prime's annual revenue.
The valuations
| Ticker | Company | Golden Dome role | EV/Sales | EV/Sales 5y %ile | Revenue growth (TTM) |
|---|---|---|---|---|---|
| RKLB | Rocket Lab | Tracking satellites | 57.5x | 82.5* | 53% |
| RTX | RTX (Raytheon) | Space-based interceptors | 2.9x | 78.0 | 12% |
| GD | General Dynamics | Space-based interceptors | 1.8x | 22.2 | 9% |
| LMT | Lockheed Martin | Space-based interceptors | 1.7x | 11.5 | 7% |
| NOC | Northrop Grumman | Space-based interceptors | 1.9x | 4.6 | 6% |
| BAH | Booz Allen Hamilton | Space-based interceptors | 1.1x | 2.9 | −7% |
Where these stand now
Current readings update separately from the article’s dated analysis.
Within its usual range
NOC's P/E of 16.6x is lower than 51% of its weekly readings over the last five years.
Within its usual range
GD's P/E of 21.5x is higher than 61% of its weekly readings over the last five years.
Above its usual range
RKLB's P/S of 42.9x is higher than 70% of its weekly readings since August 2022.
The market is not pricing Golden Dome as a windfall for the primes. Lockheed, Northrop and General Dynamics trade below their own five-year medians, and Booz Allen, whose revenue shrank 7% as civilian consulting work was cut, sits near its five-year low. Rocket Lab is the one name priced high, and its rank reflects launch and satellite growth across many customers, not Golden Dome alone. Our ranking of 24 defense stocks shows the same pattern across the whole sector.
The takeaway: Four of the five listed interceptor winners trade near the bottom of their own valuation ranges. The market is treating Golden Dome as a possible upside, not a sure thing.
Why the market is cautious
The money is not there yet. The fiscal 2027 request puts $17.1 billion of $17.9 billion for Golden Dome in the reconciliation bill. Congress's defense bills fully funded the $397 million requested in the regular budget, according to Breaking Defense, but Senate Republicans left for the midterm recess without passing the reconciliation money. The cost estimates disagree. The Pentagon's $185 billion figure compares with a Congressional Budget Office estimate of $1.2 trillion, as cited by GovCon Wire (we have not checked the CBO figure against the original report). Gen. Michael Guetlein, who runs the program, has said space-based interceptors may not proceed if they prove "prohibitively costly." New entrants are in the room. SpaceX and Anduril hold the same kind of agreement as Lockheed and Northrop. For investors in the primes, a large Golden Dome production contract is not guaranteed to go to a listed company.What to watch
- Reconciliation. Whether the Senate passes defense money after it returns on November 9, and how much of the $17.1 billion survives.
- Down-select. Which of the 12 interceptor teams moves to the next phase.
- The 2028 demonstration. A successful test would turn prototype deals into production questions.
- Contract terms. Fixed-price development has cost the primes before.
The takeaway: Golden Dome is a large program with unsettled funding and cost. The listed winners are priced as if the market expects little from it so far.
Data: SEC EDGAR XBRL filings and market prices, computed by StockResearch as of October 5, 2026. Budget figures are requests, not final appropriations. Jake is the founder of StockResearch.app, where he writes data-first research on valuation dislocations. Nothing here is investment advice or a recommendation to buy or sell any security. Do your own research.